ShangPharma (SHP -2.4%) slips after missing on its Q2 results earlier today. The company also...

|About: ShangPharma Corporation (SHP)|By:, SA News Editor

ShangPharma (SHP -2.4%) slips after missing on its Q2 results earlier today. The company also reconfirms its guidance for net revenues for FY12. Net revenues are expected to be approximately $131.7 to $136.2 million, which represents growth of approximately 18% to 22% compared with FY11. William Blair cuts the shares to Market Perform on the report.